T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Alaska Air
ALK
$5.29B
| $113M | 0.02% |
1,704,701
-748,724
| -31% | -$48.6M |
|
|
MDSO
577
DELISTED
Medidata Solutions, Inc.
MDSO
| $113M | 0.02% |
2,295,061
-640,088
| -22% | -$29.6M |
|
578
Telephone and Data Systems
TDS
$3.82B
| $112M | 0.02% |
4,506,344
+32,600
| +0.7% | +$815K |
|
579
Monster Beverage
MNST
$90.1B
| $112M | 0.02% |
9,718,848
+1,773,480
| +22% | +$18.6M |
|
|
SCU
580
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $112M | 0.02% |
883,163
+29,293
| +3% | +$3.52M |
|
581
Urban Edge Properties
UE
$2.75B
| $112M | 0.02% |
+4,706,965
| New | +$113M |
|
582
St. Joe Company
JOE
$3.87B
| $111M | 0.02% |
5,971,445
+503,770
| +9% | +$8.66M |
|
|
MNK
583
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $110M | 0.02% |
866,796
-48,814
| -5% | -$5.58M |
|
584
The Mosaic Company
MOS
$7.18B
| $110M | 0.02% |
2,379,363
+51,540
| +2% | +$2.52M |
|
585
Air Products & Chemicals
APD
$67.7B
| $108M | 0.02% |
771,847
-13,512
| -2% | -$1.87M |
|
|
MDCO
586
DELISTED
Medicines Co
MDCO
| $108M | 0.02% |
3,845,905
-42,720
| -1% | -$1.2M |
|
|
CMRX
587
DELISTED
Chimerix, Inc.
CMRX
| $108M | 0.02% |
2,857,964
+440,702
| +18% | +$17.5M |
|
|
CAVM
588
DELISTED
Cavium, Inc.
CAVM
| $107M | 0.02% |
1,509,770
-33,051
| -2% | -$2.15M |
|
|
NBIS
589
Nebius Group N.V.
NBIS
$70.5B
| $105M | 0.02% |
6,956,693
-95,800
| -1% | -$1.54M |
|
590
Amphenol
APH
$210B
| $105M | 0.02% |
7,123,904
-605,968
| -8% | -$8.48M |
|
|
PDCE
591
DELISTED
PDC Energy, Inc.
PDCE
| $105M | 0.02% |
1,938,044
+45,770
| +2% | +$2.22M |
|
592
Valmont Industries
VMI
$9.52B
| $104M | 0.02% |
845,544
-553,480
| -40% | -$67.9M |
|
|
PMCS
593
DELISTED
P M C SIERRA INC
PMCS
| $104M | 0.02% |
11,176,220
-1,251,680
| -10% | -$11.5M |
|
|
TRAK
594
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
| $103M | 0.02% |
2,682,520
+1,060,670
| +65% | +$43.1M |
|
595
Tenet Healthcare
THC
$21.5B
| $103M | 0.02% |
2,086,450
+91,790
| +5% | +$4.29M |
|
596
Helios Technologies
HLIO
$2.66B
| $103M | 0.02% |
2,495,100
-49,949
| -2% | -$1.93M |
|
|
TCO
597
DELISTED
Taubman Centers Inc.
TCO
| $103M | 0.02% |
1,331,617
+42,120
| +3% | +$3.32M |
|
|
RCPT
598
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $102M | 0.02% |
621,294
+106,121
| +21% | +$13.4M |
|
599
Wintrust Financial
WTFC
$11B
| $102M | 0.02% |
2,147,686
-333,814
| -13% | -$15.4M |
|
|
GK
600
DELISTED
G&K Services Inc
GK
| $102M | 0.02% |
1,408,840
-138,786
| -9% | -$9.84M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.